Stock listing

Everest Medicines Ltd.

Selected listing: A2QD66 · LSX · EUR · DE

Everest Medicines Ltd. (LS Exchange: A2QD66), Health Technology. Latest release Sep 28, 2026: TERMS OF REFERENCE OF THE ENVIRONMENTAL, SOCIAL AND GOVERNANCE…

A2QD66:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A2QD66
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

Latest news from Everest Medicines Ltd.

TERMS OF REFERENCE OF THE ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE

September 28, 2026

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

September 28, 2026

ESTABLISHMENT OF ENVIRONMENTAL, SOCIAL AND GOVERNANCE COMMITTEE

September 28, 2026

Next Day Disclosure Return

September 28, 2026

Everest Medicines Announces China NMPA Approval of CARDAMYST® for the Conversion of Acute Symptomatic Episodes of Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm in Adults

September 3, 2026

All Everest Medicines Ltd. news →

Research Everest Medicines Ltd.

Everest Medicines Ltd. company profile

View the public company page for Everest Medicines Ltd. on 6ix.

Everest Medicines Ltd. news

Read company news and market updates connected to Everest Medicines Ltd..

Everest Medicines Ltd. investor events

Find investor webinars, events, and replay context for Everest Medicines Ltd..